LINCOLN, NEBRASKA (RFD NEWS) — A new vaccine is showing promise in combating Highly Pathogenic Avian Influenza (HPAI), with testing currently underway in mice and dairy calves. The promising research is led by the University of Nebraska–Lincoln (UNL).
UNL Professor of Biological Sciences Eric Weaver joined us on Tuesday’s Market Day Report to provide an update on the development.
In his interview with RFD News, Weaver discussed details of the vaccine and the results from early testing. He also outlined the next steps in the research process as work continues.
Finally, Weaver explained the potential impacts this vaccine could have on the livestock industry as it continues to battle HPAI.
Related Stories
After months of declining consumer egg prices, buyers could be facing a sharp increase in costs as prices surge upwards once again.
Researchers out of the United Kingdom are using gene editing technology to help make High-Path Avian Flu less of a threat to poultry.
To mark the end of National Chicken Month, we take a look at how the U.S. poultry industry is making a slow and steady recovery following the widespread outbreak of High-Path Avian Flu (HPAI) in 2022 that devastated commercial flocks across the country.
Egg prices have been on a roller coaster this year, soaring sky-high and falling back down to Earth in just a few months.
